Literature DB >> 9685424

Regulation of G protein-coupled receptor kinase 5 (GRK5) by actin.

J L Freeman1, E M De La Cruz, T D Pollard, R J Lefkowitz, J A Pitcher.   

Abstract

G protein-coupled receptor kinases (GRKs) initiate pathways leading to the desensitization of agonist-occupied G-protein-coupled receptors (GPCRs). Here we report that the cytoskeletal protein actin binds and inhibits GRK5. Actin inhibits the kinase activity directly, reducing GRK5-mediated phosphorylation of both membrane-bound GPCRs and soluble substrates. GRK5 binds actin monomers with a Kd of 0.6 microM and actin filaments with a Kd of 0. 2 microM. Mutation of 6 amino acids near the amino terminus of GRK5 eliminates actin-mediated inhibition of GRK5. Calmodulin has previously been shown to bind to the amino terminus of GRK5 (Pronin, A. N., and Benovic, J. L. (1997) J. Biol. Chem. 272, 3806-3812) and here we show calmodulin displaces GRK5 from actin. Calmodulin inhibits GRK5-mediated phosphorylation of GPCRs, but not soluble substrates such as casein. Thus in the presence of actin, calmodulin determines the substrate specificity of GRK5 by preferentially allowing phosphorylation of soluble substrates over membrane-bound substrates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685424     DOI: 10.1074/jbc.273.32.20653

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  G-protein coupled receptor kinases as modulators of G-protein signalling.

Authors:  M Bünemann; M M Hosey
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

2.  Overlapping and distinct roles of GRK5 in TLR2-, and TLR3-induced inflammatory response in vivo.

Authors:  Nandakumar Packiriswamy; Sitaram Parvataneni; Narayanan Parameswaran
Journal:  Cell Immunol       Date:  2011-10-28       Impact factor: 4.868

Review 3.  Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity.

Authors:  Richard T Premont
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Mol Pharmacol       Date:  2009-06-02       Impact factor: 4.436

Review 5.  GRK mythology: G-protein receptor kinases in cardiovascular disease.

Authors:  Gerald W Dorn
Journal:  J Mol Med (Berl)       Date:  2009-02-20       Impact factor: 4.599

6.  G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα.

Authors:  Sonika Patial; Jiansong Luo; Katie J Porter; Jeffrey L Benovic; Narayanan Parameswaran
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

7.  TRPV1 is a physiological regulator of μ-opioid receptors.

Authors:  Paul C Scherer; Nicholas W Zaccor; Neil M Neumann; Chirag Vasavda; Roxanne Barrow; Andrew J Ewald; Feng Rao; Charlotte J Sumner; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

8.  Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4.

Authors:  Samantha J Allen; Gopal Parthasarathy; Paul L Darke; Ronald E Diehl; Rachael E Ford; Dawn L Hall; Scott A Johnson; John C Reid; Keith W Rickert; Jennifer M Shipman; Stephen M Soisson; Paul Zuck; Sanjeev K Munshi; Kevin J Lumb
Journal:  J Biol Chem       Date:  2015-07-01       Impact factor: 5.157

Review 9.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

10.  Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes.

Authors:  Jeffrey S Martini; Philip Raake; Leif E Vinge; Brent R DeGeorge; Brent DeGeorge; J Kurt Chuprun; David M Harris; Erhe Gao; Andrea D Eckhart; Julie A Pitcher; Walter J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.